Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.2.3.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.7NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FD.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FD.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
GF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GF.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
EG.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.1.5.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.24NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FL.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FU.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FU.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
GS.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GS.8NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-21719.1US
GE.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GE.1.4NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.1.5.93NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.93NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FL.2.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.2.3.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FL.4.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.4.8NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
EG.5.1.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.24NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.2.3.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.11NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.2.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-820.864US
BA.2.85NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.85NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-18328.8US
BA.2.65NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.65NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-820.864US
BA.5.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-4388.79US
BA.2.10.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.10.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.2.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.2.3.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.13NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.2.3.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.9NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.2.10.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.10.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.2.56NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.56NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.2.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used